Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

17%

4 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (2)
P 1 (1)
P 2 (3)
P 3 (2)
P 4 (2)

Trial Status

Completed14
Recruiting4
Unknown3
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT04675931Phase 2CompletedPrimary

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

NCT06064591CompletedPrimary

Host Immune and Metabolic Determinants of Sexual Conversion in Plasmodium Parasites IMMETASEX

NCT06806956Enrolling By InvitationPrimary

Severe Malaria in Remote Areas- Closing the Evidence Gap

NCT07355426CompletedPrimary

Clinical Prediction Models for Pediatric In-Hospital Death Risk in Congolese Severe Malaria Children Using Machine Learning Based-Algorithms

NCT06624631Phase 4RecruitingPrimary

PDMC Implementation Trial in Kenya

NCT05711485Not ApplicableRecruitingPrimary

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

NCT07082205Phase 3Recruiting

Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge

NCT06601712Phase 4RecruitingPrimary

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

NCT06635733Not ApplicableNot Yet Recruiting

Enhancing Pediatric Acute Care Through Adaptive E-Learning and In-Person Skills Practice in Tanzania

NCT05140278Phase 2CompletedPrimary

Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate

NCT04251351Phase 3UnknownPrimary

Effect of Paracetamol on Kidney Function in Severe Malaria

NCT05685875Unknown

Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon

NCT04176029CompletedPrimary

Lung Ultrasound in Children With Severe Malaria

NCT04473768Completed

Clinical Decision Support in Non-typhoidal Salmonella Bloodstream Infections in Children

NCT04516317CompletedPrimary

Very Severe Malaria Treated by Intravenous Artesunate

NCT04037332CompletedPrimary

Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

NCT02451904CompletedPrimary

Severe and Cerebral Malaria Investigated Through Host Metabolomics

NCT01955382Phase 2Completed

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

NCT00342043Completed

Examination of Protective Factors Against Severe Malaria

NCT00341003CompletedPrimary

Severe Malaria and Anti-malarial Drug Resistance in Cambodia

Scroll to load more

Research Network

Activity Timeline